CNS Open Data
Latest UpdatesOpen DatasetsClinical TrialsResearch GuidesTrend ReportsGlossaryData SourcesAbout

Medical & Academic Disclaimer: CNS Open Data is an academic neuroinformatics platform indexing open research datasets, preprints, and clinical trial pipelines for researchers and data scientists. Content on this site does not constitute medical advice, clinical diagnosis, or treatment recommendations.

CNS Open Data— Open Science Portal for Central Nervous System Research|Research Guides|Trend Reports|Glossary|Ranking|Open Datasets|About|Privacy Policy|Contact
AlzforumOpenNeuroDANDI ArchiveAgora (AMP-AD)
HomeOpen DatasetOpenNeuro BIDS Repository: 3T/7T 3D-FLAIR, MP2RAGE & Quantitative Susceptibility Mapping (QSM) of Paramagnetic Rim Lesions in Multiple Sclerosis
OpenNeuroMultiple SclerosisOpen DatasetBIDS / NIfTI-1
Commercial Use Allowed - CC0 Public Domain

OpenNeuro BIDS Repository: 3T/7T 3D-FLAIR, MP2RAGE & Quantitative Susceptibility Mapping (QSM) of Paramagnetic Rim Lesions in Multiple Sclerosis

October 18, 2026
Translational Neuroimmunology Imaging Group
DOI: 10.18112/openneuro.ds004420.v1.0.0

Study Design & Technical Specifications

Sample Size / Cohort

95 MS Patients & Controls

Subject / Study Model

CNS Experimental / Clinical Model

Analytical Modalities

3D FLAIR MRIQSM / SWIDTIT1w MP2RAGE

Primary Abstract & Repository Description

Source: OpenNeuro
High-resolution structural MRI, T2*-weighted phase/QSM, and multi-shell diffusion tensor imaging (DTI) dataset with manual expert lesion masks for white matter lesions, paramagnetic rim lesions (PRLs), and central vein sign (CVS) assessment.
CNS Open Data Deep Research Brief

Editorial Critique, Methodological Value & Reusability Guide

Structured via CNS Domain Knowledge Engine

1. Scientific Context & Premise

This resource from OpenNeuro ("OpenNeuro BIDS Repository: 3T/7T 3D-FLAIR, MP2RAGE & Quantitative Susceptibility Mapping (QSM) of Paramagnetic Rim Lesions in Multiple Sclerosis") addresses critical scientific questions within Multiple Sclerosis (MS). Research in this domain currently faces major translational bottlenecks, including progression independent of relapse activity (PIRA), smoldering neuroinflammation, and remyelination failure across white and cortical gray matter. By focusing on key thematic elements (BIDS, Multiple Sclerosis, 3D FLAIR, PRL, CVS), this work contributes empirical evidence toward understanding how molecular, cellular, or systems-level alterations relate to core disease pathways such as paramagnetic rim lesions (PRLs), T2/FLAIR lesion volume, oligoclonal bands, EBV titers, and EDSS progression metrics. Integrating these findings into the broader open science ecosystem helps reduce fragmentation across independent laboratories and accelerates hypothesis verification.

2. Study Architecture & Findings

Structured as an open scientific dataset, this repository leverages 3D FLAIR MRI, QSM / SWI, DTI, T1w MP2RAGE across CNS Experimental / Clinical Model (95 MS Patients & Controls). Its primary architectural value lies in providing standardized, machine-readable primary records via OpenNeuro under CC0 Public Domain. Unlike isolated summary tables in static publications, access to underlying 3D FLAIR MRI, QSM / SWI, DTI, T1w MP2RAGE distributions enables independent inspection of signal-to-noise ratios, preprocessing parameter sensitivity, and cross-modality feature extraction.

3. Secondary Analysis & Reusability

Researchers and computational neuroscientists can reuse this resource across multiple secondary workflows: (1) Cross-Cohort Harmonization & Meta-Analysis — combining these 3D FLAIR MRI, QSM / SWI, DTI, T1w MP2RAGE records with complementary repositories (such as OpenNeuro, DANDI, Agora, or Europe PMC) to increase statistical power; (2) Computational Benchmarking & Machine Learning — utilizing the documented features (BIDS, Multiple Sclerosis, 3D FLAIR, PRL, CVS) as training, validation, or out-of-distribution test sets for predictive biomarker discovery in Multiple Sclerosis (MS); and (3) Experimental Protocol Alignment — referencing the study design (CNS Experimental / Clinical Model, 95 MS Patients & Controls) to calibrate sample size calculations (power analysis) and endpoint selection for upcoming preclinical or clinical studies.

4. Methodological Caveats & Governance

While curated from an authoritative scientific source, secondary analysts should account for potential cohort selection biases and site-specific batch effects. Specifically, when interpreting 3D FLAIR MRI, QSM / SWI, DTI, T1w MP2RAGE results in Multiple Sclerosis (MS), researchers must control for confounding variables (such as age, sex, post-mortem interval, scanner/instrument drift, or medication state) and verify compliance with open-access attribution requirements (CC0 Public Domain).

Related CNS Open Data Research Playbooks & Methodology Guides
Multiple Sclerosis (MS) Open Data Guide: Federated Real-World Data (OMOP CDM) & MRI Lesion Analysis
10 min read • Open Playbook
Advanced MS Neuroimaging Pipeline: Automated Lesion Segmentation, Paramagnetic Rim Lesions (PRLs) & Spinal Cord Atrophy Quantification
14 min read • Open Playbook

Data Access, Reproducibility & Analysis Starter Guide

BIDS (Brain Imaging Data Structure) v1.9+

BIDS / NIfTI-1

Quick Data Access & Structured Export

Open the primary repository directly or download structured metadata (JSON / CSV) in one click.

Open Primary Data (OpenNeuro)Download Data

This neuroimaging resource follows the Brain Imaging Data Structure (BIDS) specification, organizing raw NIfTI volumes (.nii.gz), acquisition parameters (.json sidecars), and participant phenotype tables (participants.tsv) in a deterministic directory hierarchy.

Programmatic Data Retrieval (Python Starter Code & Recommended SDKs)

Python Quickstart: Download & Inspect BIDS Neuroimaging Dataset

# 1. Install BIDS & Neuroimaging dependencies
# pip install openneuro-py pybids nibabel pandas

import openneuro as on
from bids import BIDSLayout
import pandas as pd

# Download metadata & subject headers from OpenNeuro (ds004500)
dataset_id = "ds004500"
target_dir = f"./data/{dataset_id}"
on.download(dataset=dataset_id, target_dir=target_dir, include=["participants.tsv", "dataset_description.json", "sub-01/*"])

# Initialize PyBIDS layout and inspect subjects & modalities
layout = BIDSLayout(target_dir, validate=False)
print(f"Subjects: {layout.get_subjects()} | Modalities: {layout.get_datatypes()}")

# Load clinical / demographic phenotype table
participants = pd.read_csv(f"{target_dir}/participants.tsv", sep="\t")
print(participants.head())

Recommended Open-Source Software & SDKs

FreeSurferDesktop / CLI

Software suite for processing and analyzing human brain structural MRI images.

ANTsPy (Advanced Normalization Tools)Python SDK

Diffeomorphic image registration, cortical thickness, and lesion segmentation.

Standardized 4-Step Workflow & Governance Checklist

Standardized Acquisition & Preprocessing Workflow

1. Retrieve BIDS Hierarchy via DataLad or AWS S3 CLI

Fetch the dataset manifest and selectively download subject anatomical/functional runs without requiring authentication credentials.

2. Run BIDS-Validator & Inspect JSON Sidecars

Verify TR (Repetition Time), TE, slice timing, and scanner field strength (3T/7T) across all subjects to detect protocol deviations.

3. Standardized Preprocessing (fMRIPrep / FreeSurfer)

Execute motion correction, susceptibility distortion correction, and MNI152NLin2009cAsym template normalization.

4. Covariate Regression & Group-Level Modeling

Merge participants.tsv clinical scores with extracted ROI/parcellation metrics while controlling for age, sex, and head motion.

Reproducibility & Governance Checklist

  • Verify BIDS dataset_description.json License and HowToAcknowledge fields before publication.
  • Exclude runs exceeding framewise displacement (FD > 0.5 mm) to prevent motion-induced false positives.
  • Ensure all anatomical scans remain defaced/de-identified in derivative repositories.

Tags & Modalities

3D FLAIR MRIQSM / SWIDTIT1w MP2RAGE#BIDS#Multiple Sclerosis#3D FLAIR#PRL#CVS#DTI

Bibliometrics, Peer-Review Status & Citation Export

Cross-referenced via Semantic Scholar, Europe PMC & bioRxiv

1. Citation Metrics & Context Breakdown

0
Total Citations
0
Influential Citations

Citation Context Breakdown

Citation intent breakdown (Supporting vs. Contrasting) is currently accumulating in Semantic Scholar for this record. Researchers reusing this resource should cite the primary DOI/URL using the standardized formats below.

2. Peer-Review Validation & Revision History

Verified Publication / Open Dataset Record

Metadata and license integrity verified against primary repository records.

3. Standardized Academic Citation & BibTeX Export

Selected Format (APA)
Translational Neuroimmunology Imaging Group (2026). OpenNeuro BIDS Repository: 3T/7T 3D-FLAIR, MP2RAGE & Quantitative Susceptibility Mapping (QSM) of Paramagnetic Rim Lesions in Multiple Sclerosis. OpenNeuro. https://doi.org/10.18112/openneuro.ds004420.v1.0.0
BibTeX Entry (LaTeX / Reference Managers)
@misc{group2026open,
  title = {OpenNeuro BIDS Repository: 3T/7T 3D-FLAIR, MP2RAGE & Quantitative Susceptibility Mapping (QSM) of Paramagnetic Rim Lesions in Multiple Sclerosis},
  author = {Translational Neuroimmunology Imaging Group},
  year = {2026},
  journal = {OpenNeuro},
  howpublished = {\url{https://openneuro.org/}},
  doi = {10.18112/openneuro.ds004420.v1.0.0},
  note = {CNS Open Data: multiple_sclerosis}
}

Related Multiple Sclerosis Research & Datasets

Explore All Datasets
Clinical Trial & PipelineMS Data Alliance

MSDA: COVID19 GDSI LocalDashboard - Federated MS Data Toolkit

Official open-source repository and tool for Multiple Sclerosis federated research and data harmonization under MS-DATA-ALLIANCE.

7/31/2022Read Analysis
Clinical Trial & PipelineMS Data Alliance

Global Data Sharing Initiative (GDSI): Containerized Federated Analysis Pipeline for MS Registries

International federated research initiative and containerized query framework allowing participating national MS registries to analyze disease-modifying therapy (DMT) safety, anti-CD20 outcomes, and PIRA progression without transferring identifiable patient data.

6/15/2026Read Analysis
Peer-Reviewed PaperEurope PMC

Multiple Sclerosis and Viruses: « Liaisons Dangereuses ».

Multiple sclerosis (MS) is a complex, multifactorial neurodegenerative disease with an aetiology that is still partially elusive. Several risk factors are associated with MS development including genetic predisposition and various environmental stressors; however, recently, viral infections have gained significant attention as a crucial environmental trigger. Despite the well-established link between Epstein-Barr virus (EBV) and MS susceptibility, a single-pathogen model fails to clearly characterise the molecular cascades driving the disease, suggesting that the transition from infection to autoimmune response involves more than one viral agent. In this review we examine the speculation that the interactions among different neurotropic viruses could serve a collective causative role in MS, which is under-researched in the literature at present. We summarise contradictory evidence on the role of different viral agents, including the Herpesviridae family (Human Cytomegalovirus, EBV, Herpes Simplex Viruses HSV-1 and HSV-2, and Varicella Zoster Virus), Paramyxoviridae family (Measles Virus and Rubella Virus), Influenza virus, SARS-CoV-2, and Human Endogenous Retroviruses (HERVs). Through interplay within shared molecular pathways, immune modulation, and activation of latent infections, these viruses may collectively influence the inflammatory and demyelinating processes that characterise MS. This review evaluates the etiological role of viral interplay in MS through the cumulative and interactive effects of these pathogens. The available epidemiological, immunological, and experimental data converge on the concept that viral co-exposures act synergistically to shape MS susceptibility in genetically predisposed individuals. Characterising these viral interactions presents a new research direction for the identification of novel biomarkers and the development of preventative strategies through the targeted control of viral networks.

11/1/2026Read Analysis
PreprintmedRxiv (Neurology)

CNM-Au8 Treatment Is Associated With Reduced Chronic Lesion Tissue Expansion in Relapsing-Remitting Multiple Sclerosis

BackgroundCNM-Au8, a catalytic nanocrystalline gold suspension, is proposed to support neuronal bioenergetics, but its effect on chronic lesion evolution in multiple sclerosis (MS) has not been reported. ObjectivesTo evaluate the effect of CNM-Au8 on chronic lesion tissue expansion (CLTE). Results...

9/25/2026Read Analysis
Database / PortalMS Data Alliance

MSDA Core Dataset (CDS): Standardized Global Real-World Data Harmonization Framework for Multiple Sclerosis

The MSDA Core Dataset (CDS) establishes a 44-variable international harmonization schema mapped to the OMOP Common Data Model, enabling privacy-preserving federated analytics across global Multiple Sclerosis registries.

8/12/2026Read Analysis
Database / PortalMS Data Alliance

MSDA Global Registry & Cohort Metadata Discovery Catalogue (BigMS Network)

A centralized metadata discovery catalogue indexing over 30 national and international MS registries (>120,000 patients), detailing variable availability for EDSS, relapse history, MRI, fluid biomarkers, and DUA governance.

7/24/2026Read Analysis

Active Clinical Trials & Pipeline in Multiple Sclerosis

View Clinical Pipeline
MSBASE-GLOBAMultiple Sclerosis

MSBase & BigMS Harmonized Cohort: Quantifying Progression Independent of Relapse Activity (PIRA) Under High-Efficacy DMTs

MS Data Alliance
MSDA-COVID19MSDA

Global Data Sharing Initiative (GDSI): Containerized Federated Analysis Pipeline for MS Registries

MS Data Alliance
MSDA-GH-GDSIMultiple Sclerosis

MSDA: GDSI Mock DataGenerator - GDSI Mock data generator

MS Data Alliance

Related Data & Resources

Open Datasets

Explore Related Datasets

Find neuroimaging or multi-omics datasets relevant to this topic.

Clinical Trials

View Clinical Pipeline

Check investigational drugs, clinical trials, and clinical guidelines.

Academic Research & Medical Information Disclaimer

This page provides structured scientific metadata, methodological critiques, and open-data reusability guidelines intended strictly for neuroscience researchers and data scientists. It does not constitute medical advice, clinical diagnosis, or treatment recommendations.

Was this resource helpful?

Help improve data curation by sharing your feedback.

Open SourceDownload Data